Statistics from Altmetric.com
Crossover randomised controlled trial (titration phase) followed by parallel group randomised controlled trial (efficacy phase).
Five weeks for titration phase and 4 weeks for efficacy phase.
Six academic sites, USA; enrolment February 2001 to April 2003.
Titration phase: 165 children aged 3–5.5 years with DSM-IV attention deficit/hyperactivity disorder (ADHD) of the predominantly hyperactive or combined subtypes (Revised Conners Parent and Teacher Rating Scale hyperactive-impulsive subscale T score of 65). Efficacy phase: 114 children completing the titration phase. Exclusions: previous stimulant treatment; intolerance to methylphenidate; Children’s Global Assessment Scale impairment score ⩾50; different primary caregiver over past 6 months; Full Scale IQ score equivalent of ⩽70 on the Differential Ability Scales; less than …
For correspondence: Dr Laurence Greenhill, Division of Child and Adolescent Psychiatry, New York State Psychiatric Institute, 1051 Riverside Drive, New York, NY 10032, USA;
Sources of funding: National Institute of Mental Health, University of California Irvine, Duke University Medical Center, NYSPI/Columbia University, New York University Child Study Centre, University of California Los Angeles, Johns Hopkins University.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.